Staging of lung cancer

Patricia M de Groot; Brett W Carter; Sonia L Betancourt Cuellar; Jeremy J Erasmus

doi:10.1016/j.ccm.2015.02.004

Staging of lung cancer

Clin Chest Med. 2015 Jun;36(2):179-96, vii-viii. doi: 10.1016/j.ccm.2015.02.004. Epub 2015 Apr 11.

Authors

Patricia M de Groot¹, Brett W Carter², Sonia L Betancourt Cuellar², Jeremy J Erasmus²

Affiliations

¹ Section of Thoracic Imaging, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1478, Houston, TX 77030, USA. Electronic address: pdegroot@mdanderson.org.
² Section of Thoracic Imaging, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1478, Houston, TX 77030, USA.

PMID: 26024599
DOI: 10.1016/j.ccm.2015.02.004

Abstract

Primary lung cancer is the leading cause of cancer mortality in the world. Thorough clinical staging of patients with lung cancer is important, because therapeutic options and management are to a considerable degree dependent on stage at presentation. Radiologic imaging is an essential component of clinical staging, including chest radiography in some cases, computed tomography, MRI, and PET. Multiplanar imaging modalities allow assessment of features that are important for surgical, oncologic, and radiation therapy planning, including size of the primary tumor, location and relationship to normal anatomic structures in the thorax, and existence of nodal and/or metastatic disease.

Keywords: Lung cancer; NSCLC; TNM staging.

Publication types

Review

MeSH terms

Carcinoma, Non-Small-Cell Lung / diagnosis*
Humans
Lung Neoplasms / diagnosis*
Magnetic Resonance Imaging / methods*
Neoplasm Staging*
Positron-Emission Tomography / methods*
Tomography, X-Ray Computed / methods*